Top Melatonin Companies

Melatonin Market size was valued at USD 481.69 Million in 2024 and is poised to grow from USD 529.86 Million in 2025 to USD 1135.8 Million by 2033, growing at a CAGR of 10% during the forecast period 10%.

The melatonin market is relatively fragmented, with a high level of competition. Few large players, like Pfizer, GNC, and Neurim Pharma, now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Pharmavite ', 'Jameison ', 'Rexall Sundown, Inc. ', 'Biotics Research Corporation ', 'Pfizer Inc. ', 'Solgar Inc. ', 'GNC ', 'Xiu Zheng ', 'Church & Dwight Co., Inc. ', 'By-Health ', 'Aurobindo Pharma ', 'Aspen Holdings ', 'B Joshi Agrochem Pharma ', 'Amway Corporation ', 'Neurim Pharmaceuticals ', 'Vitafusion (Church & Dwight brand) ', 'Zenith Nutrition '

Increasing disposable income and the growing number of working professionals due to industrialization and globalization are one of the major factors for increasing instances of insomnia during recent periods. This is caused by an unhealthy lifestyle and food habits which leads to increased sodium intake and is one of the direct or indirect reasons for raising blood pressure which in turn leads to symptoms of insomnia. These will drive the demand for melatonin supplements for reducing stress and insomnia which will drive the global melatonin market during the analysis period.

Melatonin is also employed in the production of bio-based spray polyurethane foam (SPF), which is used in the packing and protection of buildings. These factors would drive the Melatonin Market in the coming years.

In 2021, the North American region dominated the global melatonin market with the largest market and revenue share. The growing problem of insomnia in developed countries due to lifestyle problems and eating habits is the major reason for the growth of demand for melatonin in the united states and Canada and will drive the melatonin market growth in the region. Moreover, according to a report released by the US national library of science in 2021, more than 40% of Canadians have a minimum of one symptom of insomnia and this huge number will propel the melatonin market growth in the North American region during the analysis period.